Veterinary Vaccines Market: By Product Type, Companion Animal Vaccine, Porcine Vaccines, Equine Vaccines, Others), By Disease Type, Companion Animal Diseases Equine Diseases, Porcine Diseases, Aquaculture Diseases, By Vaccine Type, By Distribution Channel and Region Forecast 2019-2030

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Veterinary Vaccines Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Live Stock Vaccines (Bovine Vaccines, Poultry Vaccines, Small Ruminants Vaccines), Companion Animal Vaccine (Canine Vaccines, Feline Vaccines), Porcine Vaccines, Equine Vaccines, Others), By Disease Type (Live Stock Diseases (Foot and Mouth Diseases, Brucellosis, Infectious Bronchitis, Mareket Disease, Newcastle Disease, Others), Companion Animal Diseases (Canine Distemper, Canine Parvovirus, Feline Rabies, Others) Equine Diseases, Porcine Diseases, Aquaculture Diseases, By Vaccine Type (Live Attenuated Vaccines, Inactivated Vaccines, Recombinant vaccines, Toxoid vaccines, Conjugate Vaccines, DNA Vaccines, Subunit Vaccines), By Distribution Channel ( Veterinary Pharmacies, Veterinary Hospitals, Veterinary Clinics, E-Commerce) and Region Forecast 2019-2030

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Veterinary Vaccines market size was valued at US$ 7.8 billion in 2023 and is poised to grow at a CAGR of 7.4% from 2024-2030. The rising immunization programmes in animals and increasing stakeholder involvement in containing the disease in animals. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities, and possible challenges to the key stakeholders operating in the market.

In addition, the report includes animal demographics regulatory scenario, top meat producing countries, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (Regional Investment hot spots) and market unmet needs (Product Opportunities). Key stakeholders of the market report include suppliers, manufacturers, marketers, policymakers, and veterinary healthcare service providers engaged in manufacturing and supplying veterinary vaccines products

Key Developments:

  • On June 25, 2024: Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc. announced the U.S. Department of Agriculture (US$A) approval of NOBIVAC® NXT Canine Flu H3N2, a next-level solution to help safeguard dogs against the ongoing threat of canine influenza. The product is expected to be available at veterinary clinics and hospitals nationwide H2 2024.
  • On December 28, 2023: Indian Immunologicals Limited (IIL) announced that it has started construction of its greenfield veterinary vaccine facility to manufacture the Foot and Mouth Disease Vaccine (FMD-Vac) as well as Foot and Mouth Disease + Haemorrhagic Septicaemia Vaccine (FMD + HS-Vac) in Hyderabad's Genome Valley. 

summary download arrow Download Free Sample

Global Veterinary Vaccines Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

7.4%

Largest Market

North America

Fastest Growing Market

North America

Veterinary Vaccines Market Dynamics

The rise in demand for safe and effective meat for consumption and rising trade restriction of meat and animal owing to zoonotic diseases expected to create demand for veterinary vaccines over the forecast period. For instance, Global Rinderpest Eradication Program aims at vaccination, trade restrictions, and surveillance of rinderpest in animals. Moreover, market growth is driven by improving food security and rising human and pet bondage adoption in recent times.

The growth of veterinary Vaccines market expected to hinder over forecast period owing to lack of cold chain infrastructure for vaccine storage and transportation in several developing and underdeveloped economies. Moreover, the dearth of diseases surveillance data for carving out effective immunization programs expected to impede veterinary vaccine market growth over the forecast period.

Global Veterinary Vaccines Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 7.8 billion

Market CAGR

7.4%

By Product Type

  • Live Stock Vaccines
  • Companion Animal Vaccine 
  • Porcine Vaccines,
  • Equine Vaccines,
  • Others

By Disease Type

  • Live Stock Diseases 
  • Companion Animal Diseases 
  • Equine Diseases,
  • Porcine Diseases,
  • Aquaculture Diseases

By Vaccine Type

  • Live Attenuated Vaccines,
  • Inactivated Vaccines,
  • Recombinant vaccines,
  • Toxoid vaccines,
  • Conjugate Vaccines,
  • DNA Vaccines,
  • Subunit Vaccines

By Distribution Channel

  • Veterinary Pharmacies,
  • Veterinary Hospitals,
  • Veterinary Clinics,
  • E-Commerce

By Region

  • North America (U.S., Canada)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
  • Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
  • Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

Key Features of the Report

  • The veterinary vaccines market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis in addition to recent technology advancements and innovations in the market.

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The veterinary vaccines market size was valued at US$ 7.8 billion in 2023 and is growing at a CAGR of 7.4% from 2024-2030

Increasing Incidence of Livestock Diseases

Asia Pacific is the fastest-growing in the market

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Global Veterinary Vaccines Market Introduction 
2.1.Global Global Veterinary Vaccines Market  - Taxonomy
2.2.Global Global Veterinary Vaccines Market  - Definitions
2.2.1. Product Type
2.2.2.Disease Type
2.2.3.Vaccine Type
2.2.4.Distribution Channel 
2.2.5.Region
3.Global Global Veterinary Vaccines Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Global Veterinary Vaccines Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Global Veterinary Vaccines Market  By  Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Live Stock Vaccines
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Companion Animal Vaccine 
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Porcine Vaccines,
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Equine Vaccines,
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Others
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
6.Global Global Veterinary Vaccines Market  By Disease Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Live Stock Diseases 
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Companion Animal Diseases 
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Equine Diseases,
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Porcine Diseases,
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Aquaculture Diseases
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7.Global Global Veterinary Vaccines Market  By Vaccine Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Live Attenuated Vaccines,
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Inactivated Vaccines,
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Recombinant vaccines,
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Toxoid vaccines,
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Conjugate Vaccines,
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
7.6. DNA Vaccines,
7.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.6.3. Market Opportunity Analysis 
7.7. Subunit Vaccines
7.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.7.3. Market Opportunity Analysis 
8.Global Global Veterinary Vaccines Market  By Distribution Channel , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Veterinary Pharmacies,
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Veterinary Hospitals,
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Veterinary Clinics,
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. E-Commerce
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
9.Global Global Veterinary Vaccines Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10.North America Global Veterinary Vaccines Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1.  Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Live Stock Vaccines
10.1.2.Companion Animal Vaccine 
10.1.3.Porcine Vaccines,
10.1.4.Equine Vaccines,
10.1.5.Others
10.2.  Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Live Stock Diseases 
10.2.2.Companion Animal Diseases 
10.2.3.Equine Diseases,
10.2.4.Porcine Diseases,
10.2.5.Aquaculture Diseases
10.3.  Vaccine Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Live Attenuated Vaccines,
10.3.2.Inactivated Vaccines,
10.3.3.Recombinant vaccines,
10.3.4.Toxoid vaccines,
10.3.5.Conjugate Vaccines,
10.3.6.DNA Vaccines,
10.3.7.Subunit Vaccines
10.4.  Distribution Channel  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Veterinary Pharmacies,
10.4.2.Veterinary Hospitals,
10.4.3.Veterinary Clinics,
10.4.4.E-Commerce
10.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11.Europe Global Veterinary Vaccines Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1.  Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Live Stock Vaccines
11.1.2.Companion Animal Vaccine 
11.1.3.Porcine Vaccines,
11.1.4.Equine Vaccines,
11.1.5.Others
11.2.  Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Live Stock Diseases 
11.2.2.Companion Animal Diseases 
11.2.3.Equine Diseases,
11.2.4.Porcine Diseases,
11.2.5.Aquaculture Diseases
11.3.  Vaccine Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Live Attenuated Vaccines,
11.3.2.Inactivated Vaccines,
11.3.3.Recombinant vaccines,
11.3.4.Toxoid vaccines,
11.3.5.Conjugate Vaccines,
11.3.6.DNA Vaccines,
11.3.7.Subunit Vaccines
11.4.  Distribution Channel  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Veterinary Pharmacies,
11.4.2.Veterinary Hospitals,
11.4.3.Veterinary Clinics,
11.4.4.E-Commerce
11.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
12.Asia Pacific (APAC) Global Veterinary Vaccines Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1.  Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Live Stock Vaccines
12.1.2.Companion Animal Vaccine 
12.1.3.Porcine Vaccines,
12.1.4.Equine Vaccines,
12.1.5.Others
12.2.  Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Live Stock Diseases 
12.2.2.Companion Animal Diseases 
12.2.3.Equine Diseases,
12.2.4.Porcine Diseases,
12.2.5.Aquaculture Diseases
12.3.  Vaccine Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Live Attenuated Vaccines,
12.3.2.Inactivated Vaccines,
12.3.3.Recombinant vaccines,
12.3.4.Toxoid vaccines,
12.3.5.Conjugate Vaccines,
12.3.6.DNA Vaccines,
12.3.7.Subunit Vaccines
12.4.  Distribution Channel  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Veterinary Pharmacies,
12.4.2.Veterinary Hospitals,
12.4.3.Veterinary Clinics,
12.4.4.E-Commerce
12.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13.Middle East and Africa (MEA) Global Veterinary Vaccines Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1.  Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Live Stock Vaccines
13.1.2.Companion Animal Vaccine 
13.1.3.Porcine Vaccines,
13.1.4.Equine Vaccines,
13.1.5.Others
13.2.  Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Live Stock Diseases 
13.2.2.Companion Animal Diseases 
13.2.3.Equine Diseases,
13.2.4.Porcine Diseases,
13.2.5.Aquaculture Diseases
13.3.  Vaccine Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Live Attenuated Vaccines,
13.3.2.Inactivated Vaccines,
13.3.3.Recombinant vaccines,
13.3.4.Toxoid vaccines,
13.3.5.Conjugate Vaccines,
13.3.6.DNA Vaccines,
13.3.7.Subunit Vaccines
13.4.  Distribution Channel  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Veterinary Pharmacies,
13.4.2.Veterinary Hospitals,
13.4.3.Veterinary Clinics,
13.4.4.E-Commerce
13.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14.Latin America Global Veterinary Vaccines Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
14.1.  Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Live Stock Vaccines
14.1.2.Companion Animal Vaccine 
14.1.3.Porcine Vaccines,
14.1.4.Equine Vaccines,
14.1.5.Others
14.2.  Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Live Stock Diseases 
14.2.2.Companion Animal Diseases 
14.2.3.Equine Diseases,
14.2.4.Porcine Diseases,
14.2.5.Aquaculture Diseases
14.3.  Vaccine Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Live Attenuated Vaccines,
14.3.2.Inactivated Vaccines,
14.3.3.Recombinant vaccines,
14.3.4.Toxoid vaccines,
14.3.5.Conjugate Vaccines,
14.3.6.DNA Vaccines,
14.3.7.Subunit Vaccines
14.4.  Distribution Channel  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Veterinary Pharmacies,
14.4.2.Veterinary Hospitals,
14.4.3.Veterinary Clinics,
14.4.4.E-Commerce
14.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Bayer AG (Germany)
15.2.2.Boehringer Ingelheim GmbH (Germany)
15.2.3.Ceva Sant Animale (France)
15.2.4.Eli Lilly and Company (U.S)
15.2.5.Hester biosciences (India)
15.2.6.Merck & Co., Inc. (U.S)
16. Research Methodology 
17. Appendix and Abbreviations 

Key Market Players

  • Bayer AG (Germany)
  • Boehringer Ingelheim GmbH (Germany)
  • Ceva Sant Animale (France)
  • Eli Lilly and Company (U.S)
  • Hester biosciences (India)
  • Merck & Co., Inc. (U.S)
  • Vétoquinol S.A. (France)
  • Virbac S.A. (France)
  • Zoetis Inc. (U.S)

Related Industry Reports

Egypt Diabetes Devices Market

Lithuania Surgical Equipment Market

Antimicrobials Market

Cancer Therapy Market